AstraZeneca plc vs First Trust Cloud Computing ETF — how do they compare? AstraZeneca plc trades at $158.76 (market cap $248.14B), while First Trust Cloud Computing ETF trades at $161.6. The key difference: AstraZeneca plc pays a 2.01% dividend while First Trust Cloud Computing ETF pays none, and First Trust Cloud Computing ETF is trading nearer its 52-week high, AstraZeneca plc nearer its low. Which is the better fit depends on your goals.
| AZN | SKYY | |
|---|---|---|
Market Cap | $248.14B | — |
Sector | Health | — |
52-Week High | $209.48 | $161.09 |
52-Week Low | $147.06 | $104.16 |
Enterprise Value | $275.41B | — |
Dividend Yield | 2.01% | — |
Signals from Pluang's Aura AI — not financial advice
AstraZeneca (AZN) trades at $157.39, down 2.79% amid bearish technical signals and merger speculation. The company demonstrates strong fundamentals with revenue growth to $58.74B in 2025 and a net income margin of 17.02%. Recent earnings have consistently beaten estimates, and analyst consensus is positive with 47.5% buy ratings. However, news of potential merger talks with Bristol Myers Squibb and a related legal investigation have introduced volatility.
The outlook is mixed; solid profitability and growth support long-term value, but near-term price pressure from technical indicators and merger uncertainty presents a cautious entry point. Key risks include deal execution challenges and integration complexities should a merger proceed.
First Trust Cloud Computing ETF (SKYY) trades at $163.00, up 1.38% with bullish technical signals from moving averages and ADX indicators. The ETF provides diversified exposure to cloud infrastructure, software, and AI companies, benefiting from secular trends in cloud migration and AI adoption. Recent news highlights strong institutional interest in technology ETFs and SKYY's positioning in the expanding AI ecosystem beyond semiconductors.
SKYY offers exposure to cloud computing growth drivers with technical momentum supporting near-term upside. Key risks include technology sector volatility and competitive pressures from global cloud initiatives. The ETF's diversified approach mitigates concentration risk while capturing broader technology transformation trends.
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →